Syndecan-1 (CD138) modulates breast cancer stem cell properties via regulation of IL-6-mediated STAT3 signaling

  • M Götte, SA Ibrahim, H Hassan, B Greve, R Kelsch, L Kiesel, R Reinbold
  • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group
  • DOI: 10.1055/s-0033-1336628

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Martin Götte